SAGE Toxicologic Pathology & Veterinary Science

TPX 2022 Series - EP1: Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vector

03.11.2022 - By SAGE Publications Ltd.Play

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Podcast Editor, Tracy Carlson, interviews authors Basel Assaf and Julie Hutt to discuss the article, "Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vector" which can currently be found in Vol 50, Issue 1, 2022 of Toxicologic Pathology. Click here to read the article

More episodes from SAGE Toxicologic Pathology & Veterinary Science